Preclinical Assessment of GLP-1 and Combination Therapies for Obesity: Insights from Mouse Models
Time: 9:30 am
day: Day One
Details:
- Assessment of Mono, Dual, and Tri-Agonist GLP-1 Therapies in Diet-Induced Obese and db/db Mouse Models
- Effects of GLP-1 Agonists on Weight Reduction and Body Composition in a Polygenic Mouse Model Under Ambient and Thermoneutral Conditions
- Imaging Approaches for Body Composition Assessment in Preclinical Models: Subcutaneous Fat, Visceral Adiposity, and Lean Mass
